Position in LQDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,057,034
+$1,964,407 QoQ
Shares Held
25,800
+247.1% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#120
of 333 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Derivatives in LQDA
reported options exposure · as of Jun 30, 2024CallValue
$480,000
CallShares
40,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Quarry LP holds $3,286,514 across 21 Drug Manufacturers - Specialty & Generic names. LQDA ranks #1 (62.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
This page
|
25,800 | $2,057,034 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
|
150,057 | $1,188,451 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
151 | $5,235 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
93 | $4,325 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
404 | $4,040 | |
| 6 | ZTS |
Zoetis Inc.
|
55 | $3,952 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
113 | $3,548 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
101 | $2,562 |
All Filings in LQDA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,057,034 | 25,800 | Shares | Other | 2026-08-14 | |
| 2025-06-30 | $92,627 | 7,434 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $79,487 | 5,389 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $170,000 | 17,000 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $480,000 | 40,000 | Call | Other | 2024-08-14 | |
| 2024-06-30 | $246,000 | 20,500 | Shares | Other | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||